3,4,4a,5,6,7,8,9-八氢-6-亚甲基-2H-苯并环庚烯-2-酮 | 100741-82-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3,4,4a,5,6,7,8,9-八氢-6-亚甲基-2H-苯并环庚烯-2-酮
• 英文名称: 3,4,4a,5,6,7,8,9-octahydro-6-methylene-2H-benzocyclohepten-2-one
• 英文别名: 6-methylidene-4,4a,5,7,8,9-hexahydro-3H-benzo[7]annulen-2-one
• CAS: 100741-82-0
• 化学式: C₁₂H₁₆O
• 分子量: 176.258
• InChiKey: WAKIUVUPIAVZMQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  3-乙氧基-2-环己烯-1-酮 在 氢氟酸 作用下， 生成 3,4,4a,5,6,7,8,9-八氢-6-亚甲基-2H-苯并环庚烯-2-酮
  参考文献：
  名称：

  烯丙基硅烷分子内加成到共轭二烯酮中的区域选择性

  摘要：

  烯丙基硅烷分子内加成到共轭二烯酮上显示出区域选择性随试剂和底物结构而变化。据报道创建了5-5、6-5、5-7和6-7双环系统。

  DOI：

  10.1016/s0040-4039(00)94901-3

文献信息

• Intramolecular additions of allylsilanes to conjugated dienones. The synthesis of three perforanes
  作者：George Majetich、Jean Defauw、Clay Ringold

  DOI：10.1021/jo00236a013

  日期：1988.1
• MAJETICH, G.;HULL, KEN;DEFAUW, J.;DESMOND, R., TETRAHEDRON LETT., 1985, 26, N 23, 2747-2750
  作者：MAJETICH, G.、HULL, KEN、DEFAUW, J.、DESMOND, R.

  DOI：——

  日期：——
• MAJETICH, GEORGE;DEFAUW, JEAN;RINGOLD, CLAY, J. ORG. CHEM., 53,(1988) N 1, 50-68
  作者：MAJETICH, GEORGE、DEFAUW, JEAN、RINGOLD, CLAY

  DOI：——

  日期：——
• Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators
  申请人：Palladino Michael

  公开号：US20080103328A1

  公开（公告）日：2008-05-01

  Novel compounds are disclosed that have the following chemical structures, and prodrug esters and acid-addition salts thereof, that are useful as Interleukin-1 and Tumor Necrosis Factor-α modulators, and thus are useful in the treatment of various diseases. wherein the R groups are defined as follows: if any R 3 -R 5 , R 7 , R 8 , R 11 -R 13 is not hydrogen, R 2 or R 6 or R 9 is not methyl, or R 10 is not CH 2 , then R 1 is selected from the group consisting of hydrogen, a halogen, COOH, C 1 -C 12 carboxylic acids, C 1 -C 12 acyl halides, C 1 -C 12 acyl residues, C 1 -C 12 esters, C 1 -C 12 secondary amides, (C 1 -C 12 )(C 1 -C 12 ) tertiary amides, (C 1 -C 12 )(C 1 -C 12 ) cyclic amides, (C 1 -C 12 ) amines, C 1 -C 12 alcohols, (C 1 -C 12 )(C 1 -C 12 ) ethers, C 1 -C 12 alkyls, C 1 -C 12 substituted alkyls, C 2 -C 12 alkenyls, C 2 -C 12 substituted alkenyls, and C 5 -C 12 aryls. If all R 3 -R 5 , R 7 , R 8 , R 11 -R 13 are hydrogen, R 2 , R 6 , and R 9 are each methyl, and R 10 is CH 2 , then R 1 is selected from hydrogen, a halogen, C 1 -C 12 carboxylic acids, C 1 -C 12 acyl halides, C 1 -C 12 acyl residues, C 2 -C 12 esters, C 2 -C 12 secondary amides, (C 1 -C 12 )(C 1 -C 12 ) tertiary amides, C 2 -C 12 alcohols, (C 1 -C 12 )(C 1 -C 12 ) ethers other than methyl-acetyl ether, C 2 -C 12 alkyls, C 1 -C 12 substituted alkyls, C 2 -C 12 alkenyls, C 2 -C 12 substituted alkenyls, and C 2 -C 12 aryls. R 2 and R 9 are each separately selected from hydrogen, a halogen, C 1 -C 12 alkyl, C 1 -C 12 substituted alkyls, C 2 -C 12 alkenyl, C 2 -C 12 substituted alkenyl, C 2 -C 12 alkynyl, C 1 -C 12 acyl, C 1 -C 12 alcohol, and C 5 -C 12 aryl. R 3 -R 5 , R 7 , R 8 , and R 11 -R 13 are each separately selected from hydrogen, a halogen, C 1 -C 12 alkyl, C 1 -C 12 substituted alkyls, C 2 -C 12 alkenyl, C 2 -C 12 substituted alkenyl, C 2 -C 12 alkynyl, and C 5 -C 12 aryl. R 6 is selected from hydrogen, a halogen, C 1 -C 12 alkyl, C 1 -C 12 substituted alkyls, C 2 -C 12 alkenyl, C 2 -C 12 substituted alkenyl, and C 2 -C 12 alkynyl. R 10 is selected from hydrogen, a halogen, CH 2 , C 1 -C 6 alkyl, C 1 -C 6 substituted alkyl, C 2 -C 6 alkenyl, C 2 -C 6 substituted alkenyl, C 1 -C 12 alcohol, and C 5 -C 12 aryl. Pharmaceutical compositions comprising, and uses of, therapeutically effective amounts of the above compounds and their prodrug esters, and a pharmaceutically acceptable carrier, are also disclosed, and are useful as, for example, anti-inflammatory analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, and in the treatment of cardiovascular disease, skin redness, and viral infection. Completely synthetic and semi-synthetic methods of making these compounds and their analogs, are also disclosed.
• Regioselectivity in intramolecular addition of allylsilanes to conjugated dienones
  作者：George Majetich、Ken Hull、Jean Defauw、Richard Desmond

  DOI：10.1016/s0040-4039(00)94901-3

  日期：1985.1

  The intramolecular addition of allylsilanes to conjugated dienones shows a divergence of regioselectivity as a function of reagent and substrate structure. The creation of 5-5, 6-5, 5-7, and 6-7 bicyclic ring systems is reported.

  烯丙基硅烷分子内加成到共轭二烯酮上显示出区域选择性随试剂和底物结构而变化。据报道创建了5-5、6-5、5-7和6-7双环系统。